A
Market Data
$1.34+$0.28 (+26.42%)
ANTX · Last trade
Prev Close
$1.06
Range (27d)
$1.03 – $1.34
Recent Filings
- 8-K145.4 KBAN2 Therapeutics, Inc.Jan 29, 4:45 PM ET·0001193125-26-029540
- 10-Q8.8 MBAN2 Therapeutics, Inc.Nov 12, 11:21 AM ET·0001193125-25-277673
- 8-K387.0 KBAN2 Therapeutics, Inc.Nov 12, 11:19 AM ET·0001193125-25-277662
- 10-Q8.4 MBAN2 Therapeutics, Inc.Aug 12, 4:06 PM ET·0000950170-25-107301
- 8-K347.9 KBAN2 Therapeutics, Inc.Aug 12, 4:02 PM ET·0000950170-25-107278
- 8-K257.7 KBAN2 Therapeutics, Inc.Jun 20, 7:00 AM ET·0001193125-25-143187
- 8-K16.2 MBAN2 Therapeutics, Inc.Jun 11, 7:30 AM ET·0001193125-25-138796
- 8-K149.7 KBAN2 Therapeutics, Inc.May 27, 4:30 PM ET·0001193125-25-127595
- 10-Q7.7 MBAN2 Therapeutics, Inc.May 13, 4:12 PM ET·0000950170-25-070358
- 8-K308.4 KBAN2 Therapeutics, Inc.May 13, 4:05 PM ET·0000950170-25-070305
Insiders
10- Adjuvant Capital GP, L.P.10% Owner
- Adjuvant Global Health Technology Fund DE, L.P.10% Owner
- Adjuvant Global Health Technology Fund, L.P.10% Owner
- Aziz KabeerDirector
- Chanda SanjayChief Development Officer
- Day LucyChief Financial Officer
- Easom EricDirector, Chief Executive Officer
- Eckburg PaulChief Medical Officer
- Eizen Joshua MSee Remarks
- FitzPatrick Margaret MDirector
Tickers
Addresses
business
1300 EL CAMINO REAL, SUITE 100
MENLO PARK, CA, 94025
mailing
1300 EL CAMINO REAL, SUITE 100
MENLO PARK, CA, 94025